Caffeine.
Most of the population of the world is exposed to caffeine to a greater or lesser extent since it occurs in a number of plants used in the preparation of widely consumed drinks, and has in addition a limited therapeutic use. Chromosomal abnormalities are induced by caffeine in both plant cells and in mammalian cells in culture and it also has some anti-mitotic activity. DNA-repair processes sensitive to caffeine have been demonstrated in a number of cell systems and it has been shown to affect a wide range of other cellular processes. Caffeine has potent mutagenic effects in Escherichia coli and other micro-organisms both when acting alone and in combination with other mutagens. However its mutagenic activity in Drosophila has been disputed and the available evidence suggests that it is neither mutagenic in mammals nor synergistic with other mutagens although at very high doses it appears to have some teratogenic activity in mammals.
D000818:Animals; D001419:Bacteria; D002110:Caffeine / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology*; D002273:Carcinogens; D002460:Cell Line; D002478:Cells, Cultured; D002869:Chromosome Aberrations; D002875:Chromosomes / Q000187:drug effects; D003434:Crossing Over, Genetic / Q000187:drug effects; D004260:DNA Repair / Q000187:drug effects; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008297:Male; D008938:Mitosis / Q000187:drug effects; D009153:Mutagens; D010944:Plants; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D013329:Structure-Activity Relationship; D013723:Teratogens
D002273:Carcinogens; D009153:Mutagens; D013723:Teratogens; D002110:Caffeine; D012313:RNA